拉贝塔醇会引发假阳性药物检测结果吗?
Nazmin Bithi1, Stephen D Merrigan, Gwendolyn A McMillin
1From the Department of Pathology, University of Utah, Salt Lake City, UT (NB, GAM); ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT (SDM, GAM).
拉贝塔醇可以导致错误的阳性安非他命和甲胺免疫检测结果在麦科尼. 高特异性LC-MS/MS测试可以避免这些假阳性,确保精确的药物查.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分析化学 分析化学
- 毒理学 毒理学 毒理学
背景情况:
- 拉贝塔醇是一种α-和β-上腺抗剂,用于怀孕期间的高血压.
- 以前的报道表明,labetalol可能会干扰药物查测试,导致错误的阳性结果.
研究的目的:
- 调查labetalol可能导致安非他命和其他药物的假阳性结果的潜力.
- 为了评估不同样品类型和分析方法之间的干扰.
主要方法:
- 在尿液,血,和带组织中测试了labetalol的三种度 (2.7,50,100μM).
- 样本使用41个验证的免疫试验和液体染色体-并列质谱法 (LC-MS/MS) 药物试验进行了分析.
主要成果:
- 拉贝塔醇导致胺和甲胺免疫检测结果出现错误阳性,特别是在样本中.
- 在所有样本类型中对任何药物或代谢物进行LC-MS/MS测试时,没有观察到任何虚假阳性.
- 尿液,血和带组织在高Labetalol度下,在任何方法都没有产生虚假阳性.
结论:
- 免疫试验药物查可能会产生错误的阳性对安非他胺由于labetalol,特别是在meconium.
- 高特异性的分析方法,如LC-MS/MS是可靠的,不会产生labetalol诱导的假阳性.
更多相关视频
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
相关概念视频
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Errors occurring during blood pressure monitoring
Several factors...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drug Elimination by Renal Route: Tubular Reabsorption
Desensitization and Tachyphylaxis
